Gonzales-Oria et al. [44] also found that percentages of Tregs (CD4+CD25highFOXP3+) were significantly higher in MS subjects (those with RRMS, PPMS, and CIS-clinical isolated syndrome). This evidence concerns the gene CD4 and myeloid sarcoma.